Researchers seek new pancreatic cancer biomarkers

Targeting the cancer with one of the poorest survival rates in the world, the National Cancer Institute is funding a $2.3 million project to develop new molecular biomarkers for pancreatic cancer. Researchers from Van Andel Institute and Emory University will lead the 5-year project, along with researchers from other prominent institutions in the U.S. The study will focus on carbohydrate structures on the surface of cancer cells, known as glycans, using a technique called "shotgun glycomics." Press release | Article (reg. req.)